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and comparison of the results with 
routine ambulatory evaluations
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AbstrAct
This study had the objective to verify if the presence of wearing-off phenomenon in 
patients with Parkinson’s disease (PD) could be better identified by the administration of 
the “Wearing-off Questionnaire Card” (QC). The participant patients were first evaluated 
by resident doctors in neurology and then invited to answer the QC for detection of motor 
and nonmotor wearing-off manifestations. Seventy and nine patients were enclosed in the 
study. The questionnaire revealed that 63 patients (80%) presented wearing-off, whereas the 
consultation by the resident doctors only identified 33 subjects (41%) with this phenomenon. 
The motor wearing-off manifestations were more frequent then the nonmotor. We conclude 
that the administration of the QC in patients with PD may be a useful tool for the diagnosis 
of wearing-off phenomena.
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Identificação de manifestações de wearing-off (redução do efeito da levodopa) em 
pacientes com doença de Parkinson utilizando questionário específico e comparação 
dos resultados com avaliações ambulatoriais de rotina
resumo
Este estudo teve como objetivo verificar se a presença do fenômeno wearing-off em 
pacientes com doença de Parkinson pode ser melhor identificada pela aplicação do cartão 
questionário wearing-off (QC). Os pacientes participantes foram avaliados pelos médicos 
residentes em neurologia e depois foram convidados a responder as questões do QC 
para detecção das manifestações motoras e não motoras do wearing-off. O número de 
pacientes estudados foi de 79. O questionário revelou que 63 pacientes (80%) apresentaram 
wearing-off, enquanto que a consulta dos residentes identificou apenas 33 indivíduos (41%) 
com este fenômeno. As manifestações motoras foram mais freqüentes do que as não 
motoras. Nós concluímos que a aplicação do QC em pacientes com doença de Parkinson 
pode ser uma ferramenta útil para o diagnostico do fenômeno wearing-off. 
Palavras-chave: doença de Parkinson, wearing-off, flutuações não motoras, rastreamento.
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The introduction of levodopa at the 
end of the sixties represented a milestone 
for the therapeutic management of Parkin-
son’s disease (PD). But soon after, side ef-
fects were observed with the use of this 
drug such as fluctuations (dyskinesias and 
wearing-off phenomena)1, and neuropsy-
chiatric complications 2-4.
The wearing-off phenomenon, which is 
the reduction of the effect of levodopa or 
dopaminergic agonists, is one of the fluc-
tuations manifestations and occurs when 
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the benefit of the given dose of levodopa or dopaminergic 
agonists decay before the next intake1. In the early stage 
of the disease, the therapeutic effect of a single dose of 
levodopa is stable and long lasting, sometimes for more 
than four hours. This duration surpasses the plasmatic 
half-life of levodopa (approximately 60 to 90 minutes)5.
The reasons for these complications are not complete-
ly well understood and they are possibly related to the re-
duction of dopaminergic cells and chronic use of levodo-
pa or dopaminergic agonists. With the progression of the 
disease, the duration of the effect of each dose of levodopa 
is progressively reduced and reaches the plasmatic half-
life of the drug, even though the pharmacodynamics zof 
the drug is unaltered during the course of the disease6,7.
After ten years of levodopa intake, 80 to 100% of 
the patients develop wearing-off and dyskinesias8,9, but 
these phenomena may appear after one or two years of 
the introduction of the medication in up to 50% of the 
patients1,10. Patients with earlier onset of PD are more 
susceptible to develop fluctuations10. Other risk factors 
for the development of wearing-off and dyskinesias are: 
severity of the disease, one daily intake of levodopa, and 
duration of levodopa therapy10,3. 
Although fluctuations are mainly recognized by the 
motor manifestations, they are not only restricted to the 
motor symptoms. Nonmotor fluctuations may also be 
identified and are classified into three categories: disau-
tonomic, mental (cognitive and psychiatric), and senso-
rial/ painful11.
Even though wearing-off is frequent, motor and non-
motor components may not be adequately recognized by 
the physicians. Besides, there are currently no tools to de-
tect nonmotor symptoms. Therefore, we tested the Wear-
ing-off Questionnaire Card (QC) adapted to Portuguese, an 
aid for the detection of these fluctuations, in PD patients12.
The Wearing-off Questionnaire Card comprehends 
of 19 questions related to motor and nonmotor symp-
toms of wearing-off developed by Stacy and Hauser12 and 
came from the original questionnaire with 32 symptoms1. 
This latter was designed by movement disorders special-
ists from Europe and United States, and based on reviews 
they came up with 32 symptoms and signs related to mo-
tor and nonmotor aspects of wearing-off phenomena1.
Keeping the effort to guarantee the patient percep-
tion for some symptoms, some redundancies were al-
lowed during the preparation of the original question-
naire. The wearing-off symptoms were listed randomi-
cally and their presentation to the patients were followed 
by succinct explanations with graphics which illustrated 
the temporal pattern of wearing-off phenomena in rela-
tion to levodopa intake.
The 32 items questionnaire was then tested1. The 
working group which created the Wearing-off Question-
naire simplified it for a shorter version. Since the original 
extension could compromise its administration, a new 19 
items card was developed12.
The symptoms maintained in the new questionnaire 
were the ones considered to have sensitivity for the di-
agnosis all wearing-off phenomena. Sixteen out of thirty 
two original questions tested in 300 patients were present 
in all individuals with wearing-off1 .Subtracting the redun-
dant items, 13 in total, the remaining ones guaranteed the 
detection of these phenomena in all patients presenting 
fluctuations and consequently they were inserted in the 
new questionnaire. A regression analysis was performed 
to identify other symptoms, besides the 13 items already 
mentioned, which contributed for the patients discomfort 
in such intensity that they require treatment adjustments. 
After all this process, 19 symptoms were obtained12. In this 
present study we tested the 19 items Wearing-off Ques-
tionnaire Card translated into Portuguese in PD patients.
Method
Seventy and nine patients were randomly selected 
from the Clinic of Movement Disorders of the Depart-
ment of Neurology of the University of São Paulo School 
of Medicine during the period of May to December of 
2006. In total 81 patients were invited to participate but 
two could not answer the questionnaire for logistic rea-
sons. The enrolled participants were older then thirty 
years, literate, in use of levodopa therapy, and signed the 
informed consent forms. The study was approved by the 
ethical committee of the Hospital das Clínicas of the Uni-
versity of São Paulo School of Medicine. The inclusion 
criteria for PD were in accordance to the United King-
dom Parkinson’s Disease Society brain bank diagnostic 
criteria13. For rating the severity of PD, Hoehn and Yahr 
modified scale was adopted.
Although the questionnaire was designed to be self-
rated, in this study it was administered by one examiner 
specialized in movement disorder. The enrolled patients 
indicated (when answering the QC) if one or more re-
ferred symptoms of PD listed in the questionnaire im-
proved after taking a new dose of levodopa and if these 
variations were present routinely. Therefore, if the re-
ferred symptom improved after taking the medication, 
this indicated the presence of wearing-off phenomena. 
The patients were also asked to answer which symptoms 
were more disturbing in their daily life and if other symp-
toms not listed also bothered them.
Before the interview the patients went through rou-
tine follow-up with their doctors who were fellow res-
idents at the Clinic of Movement Disorders of the De-
partment of Neurology of Hospital das Clínicas of the 
University of São Paulo School of Medicine. These physi-
cians were unaware of this study. When the residents fin-
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ished their evaluation the following question was asked: 
the patient you just saw presented wearing-off phenome-
na? Their answer was compared to the data obtained by 
the questionnaire with the intention to verify if the card 
could help to better identify wearing-off phenomena.
Results
Seventy nine patients were interviewed and the age 
ranged from 46 to 79 years old (mean=63.8, standard 
deviation=8.1). Twenty three patients were female (29%). 
The duration of the disease varied from 4 to 33 years 
(mean=12.4, standard deviation=6.8). The age of on-
set of the first symptom ranged from 30 to 70 years old 
(mean=51.5, standard deviation=10.1).
The education level of the interviewed patients was: 
nine patients had college degree (11%), four patients high-
school degree (5.06%), eight (10%) elementary school de-
gree, and fifty two (65.8%) patients did not complete the 
elementary school education. The duration for the com-
pletion of the questionnaire varied in accordance to the 
degree of the patient’s education level and ranged from 3 
to 10 minutes. The more educated the less it took to com-
plete the card. Before the administration of QC a brief ex-
planation was given about wearing-off.
Four patients (5%) were in Hoehn and Yahr stage 1.5; 
twenty and seven (34.1%) in stage 2; twenty and three 
(29.1%) in stage 2.5, and twenty and two in stage 3. Only 
2 patients were on stage 4.
The result was later checked with the resident doctors 
and the presence or absence of wearing-off was congruent 
in 49 cases (62%). From the forty nine cases, 33 (41.8%) 
were congruent to the presence of wearing-off and 16 
(20.25%) for the absence of this phenomenon. The card 
revealed that 63 (80%) of the 79 patients evaluated had 
wearing-off. All patients with wearing-off identified by the 
resident doctors were also detected by the questionnaire.
We calculated the sensitivity and specificity of the res-
ident doctor’s evaluation for the identification of wearing-
off in comparison to the ones obtained with the QC. The 
sensitivity of the resident doctor’s consultation was 52% 
and the specificity was 100% (confidence interval of 95%). 
When the patients were asked about the symptoms 
not listed in the QC but which could also lead the dis-
comfort, the most reported ones were dyskinesia, falls, 
and freezing (Table 1).
According to the patients, from all the symptoms re-
lated to the disease and the treatment included or not 
in the QC, the ones which most led to discomfort were: 
slowness, tremor, difficulty to move, and rigidity (Table 2).
All the patients with wearing-off presented at least 
one of the motor manifestations related to this compli-
cation. Forty and five (71%) presented at least one men-
tal symptom (cognitive or psychiatric), forty two (66%) 
Table 1. Symptoms not listed in the questionnaire, but also 
troublesome to the patient.
Manifestation Frequency
Dyskinesia 15.18%
Falls 11.39%
Freezing 7.59%
Constipation 3.79%
Posture alterations 3.79%
Nightmares 2.53%
Erectile dysfunction 2.53%
Increase in libido 2.53%
Difficulties to move on bed 2.53%
Somnolence 2.53%
Festination 1.26%
Hallucinations 1.26%
Urinary dysfunctions 1.26%
Insomnia 1.26%
Depression 1.26%
Symptoms not listed in the questionnaire, but also bothering.
Table 2. Symptoms which lead to more discomfort.
Manifestation Frequency
Slowness 41.77%
Tremor 30.37%
Difficulty to move 18.98%
Rigidity 12.65%
Pain 8.86%
Dyskinesia 6.32%
Falls 5.06%
Disabilities 3.79%
Anxiety 3.79%
Wearing off  3.79%
Weakness 2.53%
Cramps 2.53%
Dullness thinking 2.53%
Dependence 1.26%
Freezing 1.26%
Difficulties to move on bed 1.26%
Nausea 1.26%
Abdominal pain 1.26%
Repetitive speech 1.26%
Symptoms which lead to more discomfort.
reported at least one sensory-painful manifestation, and 
eleven (17%) had at least one disautonomic manifestation 
included in the card (sweating). 
The graphic in the Figure 1 compare the frequency of 
each wearing-off symptom between two groups. One sub-
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group represents the patients whose wearing-off symptoms 
were diagnosed by the card administration, and the other 
subgroup the one in which the symptoms were identified 
during the routine consultation. The graphic reveals that 
the most common symptoms were the motor ones. From 
the nonmotor wearing-off manifestations, anxiety was the 
most frequent. After calculating the positive and negative 
predict values for each wearing-off manifestation, it was not 
possible to determine which symptom would help to iden-
tify the phenomena in the routine consultation (p>0.05), 
this fact may be due to the small number of patients select-
ed for this study, although symptoms related as sensory-
painful (such as pain and abdominal discomfort), and anxi-
ety were more evident in the subgroup of patients in which 
the resident doctors made the diagnostic of wearing-off. 
discussion
The main purpose of this study was to evaluate if the 
Wearing-off Questionnaire Card (QC) could be a good 
tool to identify the wearing-off phenomena. We consid-
ered wearing-off when at least one of the patient’s listed 
symptoms improved after taking a new dose of dopamine 
agonist or levodopa. For the investigation of these fluctua-
tions only patients taking at least levodopa were selected.
Using the QC, wearing-off phenomena were identified 
in 80% of patients meanwhile the anamnesis taken by the 
resident doctors only recognized fluctuations in 40.5% of 
cases. Therefore in the routine consultation the presence 
of these manifestations are less susceptible to be detected.
Stacy and cols1, reported that the original question-
naire comprising 32 items, revealed that 57.1% of 300 PD 
patients evaluated had wearing-off symptoms while the 
routine interview performed by the movement disorder 
specialist detected them in 29.4% of the cases. The fre-
quency of wearing-off was lower in their study in com-
parison to ours, independently of the interview meth-
ods chosen. This difference possibly occurred because our 
group of patients was more heterogeneous in duration 
and severity of the disease.
It is worth pointing that the routine consultation iden-
tified fluctuations in only half of the cases identified by 
the questionnaire in both situations, either using the 32 
questions card or, as in our case,the 19 questions one.
Stacy et al utilized a broaden questionnaire containing 
32 questions which was the basis and adaptation for the 
19 items questionnaire adopted in our study. Although 
there are no studies comparing both the complete and 
shorten version of the QC, the last one does not seem to 
alter the sensitivity in comparison to the larger version, 
since the reduction was accomplished after meticulous 
statistical methodological analysis12. Moreover the ques-
tionnaire could be shorten even more without loosing its 
sensitivity according to what we have seen in our study. If 
only the motor wearing-off symptoms items were asked 
they would have detect all the patients with wearing-off. 
The reduction would simplify and fasten the administra-
tion of the questionnaire. But a reduction in the num-
ber of questions may reduce attention for the nonmotor 
symptoms of wearing-off, which also bother some pa-
tients, as could be noted in the Table 2 and in the Figure.
The higher sensitivity revealed by the administration 
of the questionnaire in our study may be attributed to the 
variety of listed symptoms and to the application meth-
od in which the examiner participated directly asking the 
questions as opposed to Stacy’s study1 in which the ques-
tionnaire was self-administered. This procedure was ad-
opted because the education level of our patient was low 
and the patients could face some difficulty to answer to 
the questionnaire.
The doctor may apply the QC either choosing the self-
administration or questioning method. We could have 
stratified the patients into subgroups according to their 
level of education. The patients with higher degree could 
self-administer the QC, meanwhile to the lower ones it 
could be administered by the examiner doctor. This prac-
tice could measure the impact of the doctor’s participa-
tion in the sensitivity of the questionnaire. At the same it 
Figure. Frequency of wearing-off manifestations detected by res-
ident doctors consultation (gray) and by the administration of the 
questionnaire (black).
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could measure how the education level would influence 
on the identification of wearing-off phenomena.Once the 
purpose of this study was to answer the question if QC is 
a useful tool to identify wearing-off phenomena, we chose 
to not stratify the patients in subgroups since this would 
only measure the sensitivity and specificity of the admin-
istration method in accordance to patient’s education lev-
el. Therefore we could consider the use of the question-
naire as an aiding tool to detect the presence of wearing-
off phenomena and correlated manifestations, including 
nonmotor symptoms. 
The routinely consultation performed by the resident 
doctors is broaden and has to carry for all the other aspects 
of PD so, the attention for wearing-off symptoms may be 
diluted during their interview (Table 2). Another detail 
is that the resident’s evaluation only screened the more 
impacting wearing-off symptoms but the questionnaire 
lists all symptoms including the milder ones since it was 
design to detect the presence of wearing-off phenomena, 
not the severity. Duration, frequency and the relevance 
of wearing-off were not the scope of this questionnaire.
The correct detection of wearing-off must be per-
formed in inward patients. It must correlate the fluctu-
ation symptoms and the intake of levodopa. This proce-
dure is very expensive but it is the only way to test the real 
sensitivity of the QC. According to Stacy et al.1, the devel-
op QC is the most sensible method for the detection of 
wearing-off in outpatients and has a good reliability.
Since it is very easy to use the questionnaire, it may be 
administered in routine consultation as a tool to improve 
the quality of the interview. Besides, to detect the wear-
ing-off symptom it is necessary to have positive answer in 
two questions referring to a specific symptom. This pro-
cess is easy for the patient to comprehend and may avoid 
duplicities and misunderstandings.
The importance of nonmotor symptoms of wearing-
off was demonstrated in many studies1,11,14,15,17 and it is 
important to emphasize that for some patients they cause 
more discomfort than the motor complications15. Besides, 
these symptoms may manifest independently of motor 
fluctuation1 however, their frequency tends to increase 
according to the worsening of motor symptoms1. In the 
present study nonmotor wearing-off symptoms was only 
found in patient with motor complications. The Figure 
depicts the high frequency of some nonmotor wearing-
off symptoms such as cramps and anxiety. It is also im-
portant to mention that cramps are probably related to 
dystonia caused by the reduction of plasmatic level of 
levodopa.
In Table 1 and 3 we can observe that the motor man-
ifestations are more frequently mentioned as the main 
cause for the decline in patient’s quality of life. Table 2 
shows that many of the symptoms which bother PD pa-
tients could be related to wearing-off phenomena. This 
table also demonstrates indirectly the impact and signifi-
cance of wearing-off in the quality of life of the patients.
Although the QC is not validated in Portuguese lan-
guage and our translation could potentially hinder the un-
derstanding of certain items of the questionnaire for the 
Brazilian patients, it has not affected the sensitivity and 
specificity of the QC since the patients reported no diffi-
culty to comprehend the symptoms listed in our version 
of the questionnaire.
This study showed that wearing-off phenomena was 
under recognized by the resident doctors. This result is 
similar to the one obtained by Stacy et al.1 in multicenter 
study which revealed smaller detection of wearing-off by 
the movement disorder trained neurologist during rou-
tine consultation. The Wearing-off Questionnaire Card 
is a tool of easy administration for the identification of 
wearing-off manifestations and takes approximately 5 
minutes for its completion. A better recognition of wear-
ing-off complications may improve patient’s quality of life 
since it will lead to better identification of patient’s symp-
toms and therapeutic changes. This is the first study con-
ducted in Brazil for this purpose. We may conclude that 
the questionnaire card helps to diagnose the wearing-off 
phenomena in PD patients.
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